Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma.
Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma.
复制标题
DOI:
10.1517/14728221003652471
复制
发表时间:
2010-04
影响因子:
5.8
通讯作者:
Singh RK
中科院分区:
文献类型:
--
作者:
Sharma B;Singh S;Varney ML;Singh RK
The incidence of malignant melanoma is increasing throughout the world and is currently rising faster than any other cancer in men and second only to lung cancer in women. Current strategies focused on systemic therapy for treatment of have shown no effect on survival. Therefore there is a pressing need for developing novel targeted therapeutics. Our goal is to provide an overview regarding targeting CXCR1/2 in malignant melanoma, the rationale behind these approaches and the future perspective. This review illustrates our current understanding of CXCR1/2 receptor in melanoma progression and metastasis. We describe approaches that are being developed to block CXCR1/2 activation, including low-molecular-weight antagonists, modified chemokines and antibodies directed against ligands and receptors. The chemokine receptors CXCR1 and CXCR2 and their ligands play an important role in the pathogenesis of malignant melanoma. Recent reports demonstrated that CXCR1 is constitutively expressed in all melanoma cases irrespective of stage and grade, however, CXCR2 expression was restricted to aggressive melanoma tumors,. Furthermore, modulation of CXCR1/2 expression and/or activity has been shown to regulate malignant melanoma growth, angiogenesis and metastasis, suggesting CXCR1/2 targeting as a novel therapeutic approach for malignant melanoma.
登录
查看更多内容
影响因子:
254.7
作者:
Jemal, Ahmedin;Siegel, Rebecca;Thun, Michael J.
通讯作者:
Thun, Michael J.
影响因子:
2.6
作者:
Donahue, Timothy R.;Hines, O. Joe
通讯作者:
Hines, O. Joe
影响因子:
4.4
作者:
Del Rio, L;Bennouna, S;Denkers, EY
通讯作者:
Denkers, EY
影响因子:
5
作者:
Bar-Eli, M
通讯作者:
Bar-Eli, M
影响因子:
3.6
作者:
Gebhardt, Carl;Averbeck, Marco;Simon, Jan C.
通讯作者:
Simon, Jan C.